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Tuberculosis is widespread infectious disease predominantly caused by 
Mycobacterium tuberculosis. According to World Health Organization, 10.4 million new 
cases of tuberculosis and 1.8 million deaths from tuberculosis were registered 
worldwide only in 2015. 
 In the previous work of our group it was found that 2,5- and 1,5-disubstituted 
tetrazoles and 2,5-disubstituted oxadiazoles bearing 3,5-dinitrobenzylsulfanyl 
fragment exhibited outstanding antimycobacterial activities. The aim of this work was 
to modify these lead structures by removing the methylsulfanyl linker and to prepare 







 Firstly, we prepared a series of 2- and 1-benzyl-5-(3,5-dinitrophenyl)-1H-tetrazoles 
by the reaction of 5-(3,5-dinitrophenyl)-1H-tetrazole with diversely substituted benzyl halide. 
In another part, we dealt with the preparation of tetrazole derivatives containing saturated 
nitrogen heterocycle. At first, it was necessary to prepare alkylating agents, which have been 
subsequently used for alkylation of saturated nitrogen heterocycles. Furthermore, several 
water-soluble analogs of compounds with saturated nitrogen heterocycle and high 
antimycobacterial activity were prepared. 
Figure 1: General formula of the compounds studied in this work 
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 The next task was to prepare a series of 3,5-dinitrophenyl oxadiazole 
derivatives. Two pathways were used. The first method was the reaction of acid 
chloride with 5-(3,5-dinitrophenyl)-1H-tetrazole, but the products were not isolated. 
Target oxadiazoles were obtained by the reaction of hydrazide with  
3,5-dinitrobenzoylchloride and by the subsequent closure of oxadiazole ring. 
 Seventeen of twenty prepared structures were evaluated for their 
antimycobacterial activities and some of them for their effects on mammalian cell 
viability. Some of these compounds showed comparable or higher antimycobacterial 
activity than standard antitubercular drug isoniazid.  
 
